These findings could be partly driven by the fact that younger women are at a greater risk women are at a greater risk of having more aggressive tumor characteristics (i.e., Her2+), persistent fear of recurrence, metastasis and premature mortality (Anders et al., 2009; Assi et al., 2013; Champion et al., 2014; Lee et al., 2015) compared to older women with the same diagnosis. Here, ERBB2 is linked to neoplasm.